Global PD-1 and PD-L1 Inhibitors Market Growth 2022-2028

SKU ID : LPI-19871457 | Publishing Date : 06-Jan-2022 | No. of pages : 106

Detailed TOC of Global PD-1 and PD-L1 Inhibitors Market Growth 2022-2028

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for PD-1 and PD-L1 Inhibitors by Country/Region, 2017, 2022 & 2028
    2.2 PD-1 and PD-L1 Inhibitors Segment by Type
        2.2.1 PD-1 Inhibitors
        2.2.2 PD-L1 Inhibitors
    2.3 PD-1 and PD-L1 Inhibitors Sales by Type
        2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
        2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Type (2017-2022)
        2.3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2017-2022)
    2.4 PD-1 and PD-L1 Inhibitors Segment by Application
        2.4.1 Solid Tumors
        2.4.2 Blood-related Tumors
    2.5 PD-1 and PD-L1 Inhibitors Sales by Application
        2.5.1 Global PD-1 and PD-L1 Inhibitors Sale Market Share by Application (2017-2022)
        2.5.2 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Application (2017-2022)
        2.5.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2017-2022)
3 Global PD-1 and PD-L1 Inhibitors by Company
    3.1 Global PD-1 and PD-L1 Inhibitors Breakdown Data by Company
        3.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Company (2020-2022)
        3.1.2 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2022)
    3.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Company (2020-2022)
        3.2.1 Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2022)
        3.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2022)
    3.3 Global PD-1 and PD-L1 Inhibitors Sale Price by Company
    3.4 Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers PD-1 and PD-L1 Inhibitors Product Location Distribution
        3.4.2 Players PD-1 and PD-L1 Inhibitors Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for PD-1 and PD-L1 Inhibitors by Geographic Region
    4.1 World Historic PD-1 and PD-L1 Inhibitors Market Size by Geographic Region (2017-2022)
        4.1.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Geographic Region
    4.2 World Historic PD-1 and PD-L1 Inhibitors Market Size by Country/Region (2017-2022)
        4.2.1 Global PD-1 and PD-L1 Inhibitors Annual Sales by Country/Region (2017-2022)
        4.2.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue by Country/Region
    4.3 Americas PD-1 and PD-L1 Inhibitors Sales Growth
    4.4 APAC PD-1 and PD-L1 Inhibitors Sales Growth
    4.5 Europe PD-1 and PD-L1 Inhibitors Sales Growth
    4.6 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Growth
5 Americas
    5.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country
        5.1.1 Americas PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)
        5.1.2 Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)
    5.2 Americas PD-1 and PD-L1 Inhibitors Sales by Type
    5.3 Americas PD-1 and PD-L1 Inhibitors Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region
        6.1.1 APAC PD-1 and PD-L1 Inhibitors Sales by Region (2017-2022)
        6.1.2 APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2017-2022)
    6.2 APAC PD-1 and PD-L1 Inhibitors Sales by Type
    6.3 APAC PD-1 and PD-L1 Inhibitors Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe PD-1 and PD-L1 Inhibitors by Country
        7.1.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)
        7.1.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)
    7.2 Europe PD-1 and PD-L1 Inhibitors Sales by Type
    7.3 Europe PD-1 and PD-L1 Inhibitors Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa PD-1 and PD-L1 Inhibitors by Country
        8.1.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022)
        8.1.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022)
    8.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type
    8.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors
    10.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
    10.4 Industry Chain Structure of PD-1 and PD-L1 Inhibitors
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 PD-1 and PD-L1 Inhibitors Distributors
    11.3 PD-1 and PD-L1 Inhibitors Customer
12 World Forecast Review for PD-1 and PD-L1 Inhibitors by Geographic Region
    12.1 Global PD-1 and PD-L1 Inhibitors Market Size Forecast by Region
        12.1.1 Global PD-1 and PD-L1 Inhibitors Forecast by Region (2023-2028)
        12.1.2 Global PD-1 and PD-L1 Inhibitors Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global PD-1 and PD-L1 Inhibitors Forecast by Type
    12.7 Global PD-1 and PD-L1 Inhibitors Forecast by Application
13 Key Players Analysis
    13.1 Merck
        13.1.1 Merck Company Information
        13.1.2 Merck PD-1 and PD-L1 Inhibitors Product Offered
        13.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Merck Main Business Overview
        13.1.5 Merck Latest Developments
    13.2 Bristol-Myers Squibb
        13.2.1 Bristol-Myers Squibb Company Information
        13.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered
        13.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Bristol-Myers Squibb Main Business Overview
        13.2.5 Bristol-Myers Squibb Latest Developments
    13.3 Roche
        13.3.1 Roche Company Information
        13.3.2 Roche PD-1 and PD-L1 Inhibitors Product Offered
        13.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Roche Main Business Overview
        13.3.5 Roche Latest Developments
    13.4 AstraZeneca
        13.4.1 AstraZeneca Company Information
        13.4.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered
        13.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 AstraZeneca Main Business Overview
        13.4.5 AstraZeneca Latest Developments
    13.5 Ono Pharmaceutical
        13.5.1 Ono Pharmaceutical Company Information
        13.5.2 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Offered
        13.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Ono Pharmaceutical Main Business Overview
        13.5.5 Ono Pharmaceutical Latest Developments
    13.6 Regeneron
        13.6.1 Regeneron Company Information
        13.6.2 Regeneron PD-1 and PD-L1 Inhibitors Product Offered
        13.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Regeneron Main Business Overview
        13.6.5 Regeneron Latest Developments
    13.7 Innovent
        13.7.1 Innovent Company Information
        13.7.2 Innovent PD-1 and PD-L1 Inhibitors Product Offered
        13.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Innovent Main Business Overview
        13.7.5 Innovent Latest Developments
    13.8 Hengrui Medicine
        13.8.1 Hengrui Medicine Company Information
        13.8.2 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Offered
        13.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Hengrui Medicine Main Business Overview
        13.8.5 Hengrui Medicine Latest Developments
    13.9 Junshi Biosciences
        13.9.1 Junshi Biosciences Company Information
        13.9.2 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Offered
        13.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Junshi Biosciences Main Business Overview
        13.9.5 Junshi Biosciences Latest Developments
    13.10 Merck KGaA
        13.10.1 Merck KGaA Company Information
        13.10.2 Merck KGaA PD-1 and PD-L1 Inhibitors Product Offered
        13.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Merck KGaA Main Business Overview
        13.10.5 Merck KGaA Latest Developments
14 Research Findings and Conclusion

List of Figures, Tables and Charts Available in Global PD-1 and PD-L1 Inhibitors Market Growth 2022-2028

List of Tables
    Table 1. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. PD-1 and PD-L1 Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of PD-1 Inhibitors
    Table 4. Major Players of PD-L1 Inhibitors
    Table 5. Global PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (L)
    Table 6. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 7. Global PD-1 and PD-L1 Inhibitors Revenue by Type (2017-2022) & ($ million)
    Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2017-2022)
    Table 9. Global PD-1 and PD-L1 Inhibitors Sale Price by Type (2017-2022) & (USD/ml)
    Table 10. Global PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (L)
    Table 11. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 12. Global PD-1 and PD-L1 Inhibitors Revenue by Application (2017-2022)
    Table 13. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2017-2022)
    Table 14. Global PD-1 and PD-L1 Inhibitors Sale Price by Application (2017-2022) & (USD/ml)
    Table 15. Global PD-1 and PD-L1 Inhibitors Sales by Company (2020-2022) & (L)
    Table 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2020-2022)
    Table 17. Global PD-1 and PD-L1 Inhibitors Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company (2020-2022)
    Table 19. Global PD-1 and PD-L1 Inhibitors Sale Price by Company (2020-2022) & (USD/ml)
    Table 20. Key Manufacturers PD-1 and PD-L1 Inhibitors Producing Area Distribution and Sales Area
    Table 21. Players PD-1 and PD-L1 Inhibitors Products Offered
    Table 22. PD-1 and PD-L1 Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global PD-1 and PD-L1 Inhibitors Sales by Geographic Region (2017-2022) & (L)
    Table 26. Global PD-1 and PD-L1 Inhibitors Sales Market Share Geographic Region (2017-2022)
    Table 27. Global PD-1 and PD-L1 Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global PD-1 and PD-L1 Inhibitors Sales by Country/Region (2017-2022) & (L)
    Table 30. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Country/Region (2017-2022)
    Table 31. Global PD-1 and PD-L1 Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (L)
    Table 34. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)
    Table 35. Americas PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)
    Table 37. Americas PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (L)
    Table 38. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 39. Americas PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (L)
    Table 40. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 41. APAC PD-1 and PD-L1 Inhibitors Sales by Region (2017-2022) & (L)
    Table 42. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2017-2022)
    Table 43. APAC PD-1 and PD-L1 Inhibitors Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2017-2022)
    Table 45. APAC PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (L)
    Table 46. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 47. APAC PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (L)
    Table 48. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 49. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (L)
    Table 50. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)
    Table 51. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)
    Table 53. Europe PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (L)
    Table 54. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 55. Europe PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (L)
    Table 56. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Country (2017-2022) & (L)
    Table 58. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2017-2022) & (L)
    Table 62. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2017-2022) & (L)
    Table 64. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of PD-1 and PD-L1 Inhibitors
    Table 66. Key Market Challenges & Risks of PD-1 and PD-L1 Inhibitors
    Table 67. Key Industry Trends of PD-1 and PD-L1 Inhibitors
    Table 68. PD-1 and PD-L1 Inhibitors Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. PD-1 and PD-L1 Inhibitors Distributors List
    Table 71. PD-1 and PD-L1 Inhibitors Customer List
    Table 72. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2023-2028) & (L)
    Table 73. Global PD-1 and PD-L1 Inhibitors Sales Market Forecast by Region
    Table 74. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (L)
    Table 77. Americas PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2023-2028) & (L)
    Table 79. APAC PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (L)
    Table 81. Europe PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Forecast by Country (2023-2028) & (L)
    Table 83. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2023-2028) & (L)
    Table 85. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2023-2028) & (L)
    Table 89. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Merck Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 93. Merck PD-1 and PD-L1 Inhibitors Product Offered
    Table 94. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 95. Merck Main Business
    Table 96. Merck Latest Developments
    Table 97. Bristol-Myers Squibb Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 98. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Offered
    Table 99. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 100. Bristol-Myers Squibb Main Business
    Table 101. Bristol-Myers Squibb Latest Developments
    Table 102. Roche Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 103. Roche PD-1 and PD-L1 Inhibitors Product Offered
    Table 104. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 105. Roche Main Business
    Table 106. Roche Latest Developments
    Table 107. AstraZeneca Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 108. AstraZeneca PD-1 and PD-L1 Inhibitors Product Offered
    Table 109. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 110. AstraZeneca Main Business
    Table 111. AstraZeneca Latest Developments
    Table 112. Ono Pharmaceutical Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 113. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product Offered
    Table 114. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 115. Ono Pharmaceutical Main Business
    Table 116. Ono Pharmaceutical Latest Developments
    Table 117. Regeneron Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 118. Regeneron PD-1 and PD-L1 Inhibitors Product Offered
    Table 119. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 120. Regeneron Main Business
    Table 121. Regeneron Latest Developments
    Table 122. Innovent Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 123. Innovent PD-1 and PD-L1 Inhibitors Product Offered
    Table 124. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 125. Innovent Main Business
    Table 126. Innovent Latest Developments
    Table 127. Hengrui Medicine Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 128. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Offered
    Table 129. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 130. Hengrui Medicine Main Business
    Table 131. Hengrui Medicine Latest Developments
    Table 132. Junshi Biosciences Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 133. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Offered
    Table 134. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 135. Junshi Biosciences Main Business
    Table 136. Junshi Biosciences Latest Developments
    Table 137. Merck KGaA Basic Information, PD-1 and PD-L1 Inhibitors Manufacturing Base, Sales Area and Its Competitors
    Table 138. Merck KGaA PD-1 and PD-L1 Inhibitors Product Offered
    Table 139. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue ($ Million), Price (USD/ml) and Gross Margin (2020-2022)
    Table 140. Merck KGaA Main Business
    Table 141. Merck KGaA Latest Developments
List of Figures
    Figure 1. Picture of PD-1 and PD-L1 Inhibitors
    Figure 2. PD-1 and PD-L1 Inhibitors Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate 2017-2028 (L)
    Figure 7. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. PD-1 and PD-L1 Inhibitors Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of PD-1 Inhibitors
    Figure 10. Product Picture of PD-L1 Inhibitors
    Figure 11. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2021
    Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2017-2022)
    Figure 13. PD-1 and PD-L1 Inhibitors Consumed in Solid Tumors
    Figure 14. Global PD-1 and PD-L1 Inhibitors Market: Solid Tumors (2017-2022) & (L)
    Figure 15. PD-1 and PD-L1 Inhibitors Consumed in Blood-related Tumors
    Figure 16. Global PD-1 and PD-L1 Inhibitors Market: Blood-related Tumors (2017-2022) & (L)
    Figure 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2017-2022)
    Figure 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application in 2021
    Figure 19. PD-1 and PD-L1 Inhibitors Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Company in 2021
    Figure 21. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Geographic Region in 2021
    Figure 23. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2017-2022)
    Figure 24. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Country/Region in 2021
    Figure 25. Americas PD-1 and PD-L1 Inhibitors Sales 2017-2022 (L)
    Figure 26. Americas PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 27. APAC PD-1 and PD-L1 Inhibitors Sales 2017-2022 (L)
    Figure 28. APAC PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 29. Europe PD-1 and PD-L1 Inhibitors Sales 2017-2022 (L)
    Figure 30. Europe PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales 2017-2022 (L)
    Figure 32. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue 2017-2022 ($ Millions)
    Figure 33. Americas PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021
    Figure 34. Americas PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021
    Figure 35. United States PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2021
    Figure 40. APAC PD-1 and PD-L1 Inhibitors Revenue Market Share by Regions in 2021
    Figure 41. China PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021
    Figure 48. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021
    Figure 49. Germany PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2021
    Figure 56. Egypt PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country PD-1 and PD-L1 Inhibitors Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of PD-1 and PD-L1 Inhibitors in 2021
    Figure 62. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
    Figure 63. Industry Chain Structure of PD-1 and PD-L1 Inhibitors
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles